Virpax Pharmaceuticals (VRPX) Institutional Ownership $0.29 -0.01 (-3.42%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Virpax Pharmaceuticals (NASDAQ:VRPX)CurrentInstitutional OwnershipPercentage32.23%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$79.58KNumber ofInstitutional Sellers(last 12 months)0 Get VRPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VRPX Institutional Buying and Selling by Quarter Virpax Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/10/2024Garden State Investment Advisory Services LLC57,300$40K0.0%N/A1.172% 11/15/2024Garden State Investment Advisory Services LLC57,300$40K0.0%N/A1.172% 11/15/2023Sabby Management LLC292,790$234K0.2%-26.8%2.500% 5/13/2022Warberg Asset Management LLC17,710$39K0.0%N/A0.151% 11/17/2021Altium Capital Management LP271,846$1.31M0.3%N/A2.320% 11/16/2021National Asset Management Inc.18,600$90K0.0%N/A0.159% 11/2/2021Cambridge Investment Research Advisors Inc.19,420$93K0.0%N/A0.166% 9/17/2021Virtu Financial LLC23,625$107K0.0%N/A0.468% 8/16/2021Sabby Management LLC154,737$704K0.1%-22.6%3.120% 8/12/2021Saltoro Capital LP17,615$80K0.0%-34.8%0.355% 5/14/2021HN Saltoro Capital LP27,000$127K0.0%N/A0.546% (Data available from 1/1/2016 forward) VRPX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VRPX shares? During the previous two years, the following institutional investors and hedge funds held shares of Virpax Pharmaceuticals shares: Sabby Management LLC ($234K), Garden State Investment Advisory Services LLC ($40K).Learn more on VRPX's institutional investors. What percentage of Virpax Pharmaceuticals stock is owned by institutional investors? 32.23% of Virpax Pharmaceuticals stock is owned by institutional investors. Learn more on VRPX's institutional investor holdings. Which institutional investors have been buying Virpax Pharmaceuticals stock? The following institutional investors have purchased Virpax Pharmaceuticals stock in the last 24 months: Garden State Investment Advisory Services LLC ($114.60K). How much institutional buying is happening at Virpax Pharmaceuticals? Institutional investors have bought a total of 114,600 shares in the last 24 months. This purchase volume represents approximately $79.58K in transactions. Which Virpax Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Virpax Pharmaceuticals stock in the last 24 months: Sabby Management LLC ($107.21K). How much institutional selling is happening at Virpax Pharmaceuticals? Institutional investors have sold a total of 107,210 shares in the last 24 months. This volume of shares sold represents approximately $857.57K in transactions. Related Companies VIRX Major Shareholders APM Major Shareholders ABVC Major Shareholders CNSP Major Shareholders GLTO Major Shareholders KZIA Major Shareholders GRI Major Shareholders ADIL Major Shareholders ALZN Major Shareholders TRIB Major Shareholders This page (NASDAQ:VRPX) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRPX Stock Alerts